Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNAJB12 pseudogene 1 (DNAJB12P1) is a non-functional genomic element derived from the DNAJB12 gene, a member of the DnaJ/Hsp40 chaperone protein family. Pseudogenes like DNAJB12P1 lack protein-coding potential and do not serve as direct therapeutic targets, receptors, or active enzymes[2]. The authentic DNAJB12 protein participates in endoplasmic reticulum–mediated protein quality control, folding, and degradation of transmembrane proteins such as CFTR, but these attributes do not apply to its pseudogene derivatives[1][3].\n\nClarification: There is no evidence suggesting DNAJB12P1 acts as a receptor, enzyme, or clinically actionable molecule. If your interest is in molecular targets or therapeutic candidates, only the functional DNAJB12 gene/protein is applicable, not DNAJB12P1. Most curated protein databases do not list molecular function, drug interactions, or clinical significance for DNAJB12P1 because it is a pseudogene[2].\n\nFor structured data, DNAJB12 pseudogene 1 (DNAJB12P1) should be classified as not a therapeutic target and its entry marked as incorrect if evaluating for traditional molecular drug target potential.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNAJB12 pseudogene 1 (DNAJB12P1).